PT79411B - Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride - Google Patents
Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochlorideInfo
- Publication number
- PT79411B PT79411B PT79411A PT7941184A PT79411B PT 79411 B PT79411 B PT 79411B PT 79411 A PT79411 A PT 79411A PT 7941184 A PT7941184 A PT 7941184A PT 79411 B PT79411 B PT 79411B
- Authority
- PT
- Portugal
- Prior art keywords
- prazosina
- hydrochloride
- preparing
- stable crystalline
- novel anhydrous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI842544A FI79107C (fi) | 1984-06-25 | 1984-06-25 | Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid. |
Publications (2)
Publication Number | Publication Date |
---|---|
PT79411A PT79411A (en) | 1984-11-01 |
PT79411B true PT79411B (en) | 1986-09-15 |
Family
ID=8519293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT79411A PT79411B (en) | 1984-06-25 | 1984-10-26 | Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride |
Country Status (17)
Country | Link |
---|---|
US (2) | US4739055A (pt) |
JP (1) | JPS6115881A (pt) |
AT (1) | AT389117B (pt) |
AU (1) | AU566814B2 (pt) |
BE (1) | BE900925A (pt) |
CH (1) | CH661045A5 (pt) |
DE (1) | DE3429415A1 (pt) |
FI (1) | FI79107C (pt) |
FR (1) | FR2567124B1 (pt) |
GB (1) | GB2160861B (pt) |
IL (1) | IL73267A (pt) |
IT (1) | IT1224142B (pt) |
LU (1) | LU85616A1 (pt) |
NL (1) | NL8403250A (pt) |
NZ (1) | NZ209962A (pt) |
PT (1) | PT79411B (pt) |
ZA (1) | ZA85910B (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0237608B1 (de) * | 1986-03-21 | 1992-01-29 | HEUMANN PHARMA GMBH & CO | Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung |
JP2756846B2 (ja) * | 1989-12-28 | 1998-05-25 | 住化ファインケム株式会社 | 無水のε型結晶体2―〔4―(2―フロイル)ピペラジン―1―イル〕―4―アミノ―6,7―ジメトキシキナゾリン塩酸塩及びその製造方法 |
JPH07206857A (ja) * | 1993-12-28 | 1995-08-08 | Synthelabo Sa | アルフゾシン塩酸塩の二水和物 |
ES2282386T3 (es) * | 2001-02-24 | 2007-10-16 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Derivados de xantina, su preparacion y su uso como medicamentos. |
US7407955B2 (en) * | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
US7501426B2 (en) * | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
DE102004054054A1 (de) * | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
DE102005035891A1 (de) * | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
EP1852108A1 (en) * | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
CA2810522A1 (en) | 2006-05-04 | 2007-11-15 | Boehringer Ingelheim International Gmbh | Polymorphs |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
KR101610005B1 (ko) * | 2007-08-17 | 2016-04-08 | 베링거 인겔하임 인터내셔날 게엠베하 | Fab 관련 질환의 치료에 사용하기 위한 푸린 유도체 |
AR071175A1 (es) * | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
BRPI0917675A2 (pt) * | 2008-08-15 | 2015-12-01 | Boehringer Ingelheim Int | compostos orgânicos para cura de ferida |
EP2344195A2 (en) | 2008-09-10 | 2011-07-20 | Boehringer Ingelheim International GmbH | Combination therapy for the treatment of diabetes and related conditions |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
JP2012512848A (ja) | 2008-12-23 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 有機化合物の塩の形態 |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
BR112012012641A2 (pt) | 2009-11-27 | 2020-08-11 | Boehringer Ingelheim International Gmbh | TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA |
CA2797310C (en) | 2010-05-05 | 2020-03-31 | Boehringer Ingelheim International Gmbh | Glp-1 receptor agonist and dpp-4 inhibitor combination therapy |
AU2011268940B2 (en) | 2010-06-24 | 2015-05-21 | Boehringer Ingelheim International Gmbh | Diabetes therapy |
AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
US8962636B2 (en) | 2011-07-15 | 2015-02-24 | Boehringer Ingelheim International Gmbh | Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
EP2849755A1 (en) | 2012-05-14 | 2015-03-25 | Boehringer Ingelheim International GmbH | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
WO2015128453A1 (en) | 2014-02-28 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Medical use of a dpp-4 inhibitor |
EP4233840A3 (en) | 2016-06-10 | 2023-10-18 | Boehringer Ingelheim International GmbH | Combinations of linagliptin and metformin |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2969375A (en) * | 1961-01-24 | Certification of correction | ||
DE156532C (pt) * | ||||
NL54420C (pt) * | 1937-05-25 | |||
GB1156973A (en) * | 1965-07-06 | 1969-07-02 | Quinazoline Derivatives | |
US3433788A (en) * | 1966-04-27 | 1969-03-18 | Union Carbide Corp | Process for recovery of amines from aqueous solutions by solvent treatment and distillation |
US3421983A (en) * | 1967-03-07 | 1969-01-14 | Lummus Co | Azeotropic distillation of aqueous toluene diamine |
US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
US3743672A (en) * | 1970-05-27 | 1973-07-03 | Halcon International Inc | Separation of water in alkylene glycol mono and diester purification by azeotropic distillation |
GB1308718A (en) * | 1970-07-01 | 1973-03-07 | Sir Soc Italiana Resine Spa | Method of separating vinyl acetate from liquid mixtures |
IT956765B (it) * | 1972-06-22 | 1973-10-10 | Montedison Spa | Procedimento per la purificazione di 1 3 diossolano |
US3935213A (en) * | 1973-12-05 | 1976-01-27 | Pfizer Inc. | Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives |
US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
US4001237A (en) * | 1976-02-18 | 1977-01-04 | Bristol-Myers Company | Oxazole, isoxazole, thiazole and isothiazole amides |
US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
FI67699C (fi) * | 1979-01-31 | 1985-05-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan |
FI64367C (fi) * | 1980-02-26 | 1986-08-05 | Orion Yhtymae Oy | Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid |
-
1984
- 1984-06-25 FI FI842544A patent/FI79107C/fi not_active IP Right Cessation
- 1984-08-09 DE DE19843429415 patent/DE3429415A1/de active Granted
- 1984-10-03 GB GB08424999A patent/GB2160861B/en not_active Expired
- 1984-10-15 US US06/660,871 patent/US4739055A/en not_active Expired - Lifetime
- 1984-10-19 IL IL73267A patent/IL73267A/xx not_active IP Right Cessation
- 1984-10-19 AU AU34510/84A patent/AU566814B2/en not_active Ceased
- 1984-10-23 NZ NZ209962A patent/NZ209962A/en unknown
- 1984-10-24 IT IT23292/84A patent/IT1224142B/it active
- 1984-10-25 NL NL8403250A patent/NL8403250A/nl not_active Application Discontinuation
- 1984-10-26 FR FR8416401A patent/FR2567124B1/fr not_active Expired - Fee Related
- 1984-10-26 PT PT79411A patent/PT79411B/pt not_active IP Right Cessation
- 1984-10-26 CH CH5142/84A patent/CH661045A5/de not_active IP Right Cessation
- 1984-10-29 BE BE0/213911A patent/BE900925A/fr not_active IP Right Cessation
- 1984-10-29 JP JP59227640A patent/JPS6115881A/ja active Granted
- 1984-10-29 LU LU85616A patent/LU85616A1/fr unknown
- 1984-10-30 AT AT0344184A patent/AT389117B/de not_active IP Right Cessation
-
1985
- 1985-02-06 ZA ZA85910A patent/ZA85910B/xx unknown
-
1988
- 1988-02-08 US US07/153,780 patent/US4873330A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI842544A (fi) | 1985-12-26 |
NL8403250A (nl) | 1986-01-16 |
IL73267A (en) | 1988-06-30 |
FI842544A0 (fi) | 1984-06-25 |
BE900925A (fr) | 1985-02-15 |
GB8424999D0 (en) | 1984-11-07 |
GB2160861B (en) | 1987-11-18 |
LU85616A1 (fr) | 1985-06-04 |
NZ209962A (en) | 1987-06-30 |
AU566814B2 (en) | 1987-10-29 |
FR2567124B1 (fr) | 1990-09-21 |
ZA85910B (en) | 1985-09-25 |
FR2567124A1 (fr) | 1986-01-10 |
FI79107C (fi) | 1989-11-10 |
DE3429415C2 (pt) | 1990-05-03 |
CH661045A5 (de) | 1987-06-30 |
PT79411A (en) | 1984-11-01 |
DE3429415A1 (de) | 1986-01-02 |
US4873330A (en) | 1989-10-10 |
IT1224142B (it) | 1990-09-26 |
GB2160861A (en) | 1986-01-02 |
AT389117B (de) | 1989-10-25 |
JPS6115881A (ja) | 1986-01-23 |
JPH0481993B2 (pt) | 1992-12-25 |
US4739055A (en) | 1988-04-19 |
AU3451084A (en) | 1986-01-02 |
IT8423292A0 (it) | 1984-10-24 |
IL73267A0 (en) | 1985-01-31 |
ATA344184A (de) | 1989-03-15 |
FI79107B (fi) | 1989-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT79411B (en) | Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride | |
EG18398A (en) | Process for preparing of piperazinyl-heterocyclic compounds | |
HUT44257A (en) | Process for preparing crystalline cefalosporinhydrate | |
EG19303A (en) | Process for preparing of new therapeutically active compound | |
DE3573066D1 (en) | Process for preparing a solution of inverted micellae | |
CS489688A2 (en) | Method of crystalline citromycindihydrate production | |
BG49825A3 (en) | Method for preparing of 10- dihydro- 10- deoxo- 11- asaeritronolides a | |
PT80916A (en) | Process for preparing novel crystal modification | |
PT81566B (en) | Process for preparing amino-salicylic acid derivatives | |
ZA859130B (en) | Synthesis of a crystalline silicoalumino phosphate | |
PT83480A (en) | Process for preparing amine salts of lignosulfonates | |
PT82308A (en) | Process for preparing pesticidal compositions containing a novel anilinobenzodioxole compound | |
HUT40115A (en) | Process for preparing sylbinine free of isosylbine | |
YU184588A (en) | Process for obtaining crystalline monohydrate form of 1-carbacephalosporine | |
PT79792A (en) | Process for preparing crystalline silicic acid and salts thereof | |
DE3563208D1 (en) | A process for producing n-substituted maleimides | |
HUT43992A (en) | Process for production of crystalline metall-gluconates | |
PL256016A1 (en) | Process for preparing novel derivatives of 6-hydroxymethylpenicillanic acid | |
GB2164326B (en) | Process for synthesis of crystalline aluminosilicate | |
HUT38357A (en) | Process for producing a cepheme-carboxylic acid derivative /cephtazidim/ | |
EG17668A (en) | Process for preparing of a bromodichlorimidazole insecticide | |
YU45030B (en) | Process for preparing crystalline cimetidine | |
HUT36800A (en) | Process for preparing carbamidic acid derivatives | |
CS987985A1 (en) | Crystalline form of a 1-benzydril-4-aryl--piperazindyhydrochloride and process for preparing thereof | |
GR871051B (en) | A process for preparing an acylated heterocyclic compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19960331 |